Safety and immunogenicity of 13-Valent pneumococcal conjugate vaccine in healthy infants in Shanghai during the COVID-19 pandemic: a prospective cohort study

BackgroundStreptococcus pneumoniae (S. pneumoniae) is a major cause of morbidity and mortality in infants, leading to diseases like pneumonia and otitis media. Although the World Health Organization (WHO) recommends inclusion of pneumococcal conjugate vaccines (PCVs) in national immunization program...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Lijing Xin, Liang Hong, Sijie Wang, Xiaohua Qian, Yue Li
Formato:	Artigo
Idioma:	Inglês
Publicado em:	Frontiers Media S.A. 2026-03-01
Colecção:	Frontiers in Immunology
Assuntos:	13-Valent pneumococcal conjugate vaccine immunogenicity infants safety Streptococcus pneumoniae
Acesso em linha:	https://www.frontiersin.org/articles/10.3389/fimmu.2026.1766313/full
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!